Data from WESTRAX Randomization Sheet Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years with confirmed HIV acquired after age 9 with CD4+ T cells
Clinical and immunological status of patients at ARV treatment initiation (N = 7278 people living with HIV with ARV treatment initiated between 2006 and 2017 in Kinshasa).